Centrifuge Raises $15M in Series A Funding
Centrifuge, an onchain finance startup, raised $15m in Series A funding.
Centrifuge, an onchain finance startup, raised $15m in Series A funding.
UniUni, a Richmond, BC, Canada-based company which specializes in e-commerce last-mile logistics, raised US$50M in Series C funding.
Avive Solutions, a San Francisco, CA-based developer of a connected automated external defibrillator (AED) – the Avive Connect AEDⓇ, raised $56.5M in Growth Equity funding.
Pathios Therapeutics, an Oxford, UK-based biotech company focused on the development of therapies for cancer, raised $25M in first closed of Series B funding.
Nava Health, a Columbia, MD-based group of holistic health and treatment centers focused on integrative medicine, raised an undisclosed amount in revenue-based funding from Decathlon Capital.
Hatch, a NYC-based provider of AI-powered donor engagement solutions for nonprofits, raised $3M in Seed funding.
Neurenati Therapeutics, a Montreal, Québec, Canada-based biotech company dedicated to developing therapies for rare diseases, raised $1.38M in funding.
Metsera, a NYC-based clinical-stage biopharmaceutical company, raised $290M in funding.
GA Drilling, a Houston, TX-based company which specializes in deep geothermal energy, raised $15M in funding.
Verne, a San Francisco, CA-based developer of high-density hydrogen storage systems, raised an undisclosed amount in funding.
SWTCH Energy, a Toronto, Canada-based company providing electric vehicle (EV) charging solutions for multi-tenant buildings across North America, raised $27.2M in Series B funding.
Calzar, a San Francisco, CA-based company empowering software businesses to sell and grow revenue through cloud marketplaces (AWS, Azure, and GCP), raised $10M in Series A funding.
dataplor, a Manhattan Beach, CA-based provider of global location intelligence solutions, raised $10.6M in Series A funding.
Allen Control Systems, an Austin, TX-based defense technology company, raised $12M in Seed funding.
Cognivia, a Mont-Saint-Guibert, Belgium-based AI company dedicated to innovating pharmaceutical and biotech clinical research, raised €15.5M in funding.